Holen Sie sich die Stockscreener-App
14.11
0.98%
-0.14
Handel nachbörslich:
14.12
0.010
+0.07%
Schlusskurs vom Vortag:
$14.25
Offen:
$14.26
24-Stunden-Volumen:
199.60K
Relative Volume:
0.83
Marktkapitalisierung:
$403.75M
Einnahmen:
$30.43M
Nettoeinkommen (Verlust:
$-18.15M
KGV:
-20.45
EPS:
-0.69
Netto-Cashflow:
$-9.08M
1W Leistung:
-2.22%
1M Leistung:
+16.32%
6M Leistung:
+21.12%
1J Leistung:
+130.93%
1-Tages-Spanne:
$14.10
$14.80
1-Wochen-Bereich:
$12.85
$14.80
52-Wochen-Spanne:
$5.11
$19.22
Clearpoint Neuro Inc Stock (CLPT) Company Profile
Firmenname
Clearpoint Neuro Inc
Sektor
Branche
Telefon
(949) 900-6833
Adresse
120 S. SIERRA AVENUE, SOLANA BEACH, CA
Vergleichen Sie CLPT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLPT
Clearpoint Neuro Inc
|
14.11 | 403.75M | 30.43M | -18.15M | -9.08M | -0.69 |
|
ABT
Abbott Laboratories
|
133.24 | 231.09B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.86 | 155.24B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.92 | 144.54B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.48 | 108.82B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.68 | 44.31B | 5.54B | 4.18B | 623.10M | 7.00 |
Clearpoint Neuro Inc Stock (CLPT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-25 | Fortgesetzt | B. Riley Securities | Buy |
| 2023-10-24 | Eingeleitet | Stifel | Buy |
| 2023-02-16 | Fortgesetzt | B. Riley Securities | Buy |
| 2022-04-05 | Fortgesetzt | B. Riley Securities | Buy |
| 2021-03-18 | Eingeleitet | Lake Street | Buy |
| 2020-07-17 | Eingeleitet | B. Riley FBR | Buy |
Alle ansehen
Clearpoint Neuro Inc Aktie (CLPT) Neueste Nachrichten
Tower Research Capital LLC TRC Takes $93,000 Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - The AM Reporter
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Shares Bought by Barclays PLC - Defense World
ClearPoint Neuro (CLPT) to Release Earnings on Tuesday - Defense World
(CLPT) Technical Data - news.stocktradersdaily.com
After Leaping 31% ClearPoint Neuro, Inc. (NASDAQ:CLPT) Shares Are Not Flying Under The Radar - simplywall.st
ClearPoint Neuro: Fundamentals Continue To Strengthen - Seeking Alpha
ClearPoint Neuro (CLPT) Expands Use of Prism Neuro Laser with FD - GuruFocus
ClearPoint Neuro, Together with its Partner Clinical Laserthermi - GuruFocus
ClearPoint Neuro expands FDA application for MRI system - Investing.com
Press Release Distribution & PR Platform - ACCESS Newswire
ClearPoint Neuro FDA Filing Could Double Market Access for Laser Therapy System | CLPT Stock News - Stock Titan
Invesco Ltd. Purchases Shares of 247,977 ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
Clinical Laserthermia Systems, together with its partner ClearPoint Neuro, announces FDA submission to expand the labeling of ClearPoint Prism® to include 1.5 T MRI guidance - TradingView
Geode Capital Management LLC Has $4.37 Million Holdings in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
The five-year returns have been incredible for ClearPoint Neuro (NASDAQ:CLPT) shareholders despite underlying losses increasing - Yahoo Finance
ClearPoint Neuro Inc (CLPT) Shares Up 7.42% on Apr 25 - GuruFocus
B. Riley Adjusts Price Target on ClearPoint Neuro to $28 From $20, Maintains Buy Rating - marketscreener.com
B. Riley Boosts ClearPoint Neuro (CLPT) Price Target, Affirms Bu - GuruFocus
Lake Street Sticks to Its Buy Rating for ClearPoint Neuro (CLPT) - The Globe and Mail
ClearPoint Neuro to Announce First Quarter 2025 Results May 13, 2025 | CLPT Stock News - GuruFocus
ClearPoint Neuro Earnings: Brain Navigation Tech Leader Sets Q1 2025 Financial Review - Stock Titan
Shareholders have faith in loss-making ClearPoint Neuro (NASDAQ:CLPT) as stock climbs 17% in past week, taking five-year gain to 280% - simplywall.st
ClearPoint Neuro (CLPT) Launches Enhanced Navigation Software to Improve OR Accessibility | CLPT Stock News - GuruFocus
ClearPoint Neuro Announces Full Market Release of ClearPoint Nav - GuruFocus
ClearPoint Neuro Announces Full Market Release of ClearPoint Navigation Software Version 3.0 -- Delivering the First End-to-End ClearPoint Navigation Solution to the Operating Room | CLPT Stock News - GuruFocus
Game-Changing Surgical Navigation Software Eliminates MRI Requirement in Operating Rooms - Stock Titan
LPL Financial LLC Buys 1,750 Shares of ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
How to Take Advantage of moves in (CLPT) - news.stocktradersdaily.com
Vanguard Group Inc. Purchases 5,400 Shares of ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
ClearPoint Neuro (NASDAQ:CLPT) versus Avinger (NASDAQ:AVGR) Head to Head Analysis - The AM Reporter
Head to Head Analysis: ClearPoint Neuro (NASDAQ:CLPT) vs. Avinger (NASDAQ:AVGR) - Defense World
Financial Analysis: ClearPoint Neuro (NASDAQ:CLPT) vs. enVVeno Medical (NASDAQ:NVNO) - Defense World
ClearPoint Neuro (NASDAQ:CLPT) Given New $25.00 Price Target at Stifel Nicolaus - Defense World
Stifel raises Clearpoint Neuro stock target to $25 on growth potential - Investing.com Canada
Here's Why We're Not Too Worried About ClearPoint Neuro's (NASDAQ:CLPT) Cash Burn Situation - Yahoo
Both individual investors who control a good portion of ClearPoint Neuro, Inc. (NASDAQ:CLPT) along with institutions must be dismayed after last week's 11% decrease - simplywall.st
ClearPoint Neuro Inc (CLPT) Shares Gap Down to $13.235 on Mar 25 - GuruFocus.com
When (CLPT) Moves Investors should Listen - news.stocktradersdaily.com
Connor Clark & Lunn Investment Management Ltd. Reduces Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
ClearPoint Neuro (CLPT) to Release Quarterly Earnings on Tuesday - Defense World
MRI Interventions, Inc. Announces 2016 Fourth Quarter and Full Year Results - ACCESS Newswire
How To Trade (CLPT) - Stock Traders Daily
What is B. Riley’s Forecast for CLPT FY2025 Earnings? - Defense World
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Analysts Are Pretty Bullish On The Stock After Recent Results - Yahoo Finance
Taylor Frigon Capital Management LLC Sells 162,551 Shares of ClearPoint Neuro, Inc. (NASDAQ:CLPT) - MarketBeat
ClearPoint Neuro: Drug Delivery Prospects Continue To Strengthen - Seeking Alpha
Finanzdaten der Clearpoint Neuro Inc-Aktie (CLPT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.11%
0.79%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):